Concepedia

Hong Ren

HR

Statistics

Publications

7

Citations

383

H-Index

7

Active since

2012

Affiliations

Central South University(Current)

Xiangya Hospital Central South University

Third Xiangya Hospital

The University of Texas MD Anderson Cancer Center

University of California, Los Angeles

Hong Ren is an author at Central South University specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2012–2024

7

Publications

7

Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer

Hong Ren, Zhiping Tan, Xin Zhu et al. · Cancer Research · 2012 · 127 citations

, , +17

Zilovertamab Vedotin Targeting of ROR1 as Therapy for Lymphoid Cancers

Michael Wang, Jacqueline C. Barrientos, Richard R. Furman et al. · NEJM Evidence · 2021 · 77 citations

, , +15

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas

Michelle A. Fanale, Steven M. Horwitz, Andres Forero‐Torres et al. · Blood · 2018 · 64 citations · Full text

, , +11

Co‐delivery Nano System of MS‐275 and V‐9302 Induces Pyroptosis and Enhances Anti‐Tumor Immunity Against Uveal Melanoma

Hong Ren, Zhenkai Wu, Jia Tan et al. · Advanced Science · 2024 · 41 citations · Full text

, , +17

cGAS‐STING Pathway Activation and Systemic Anti‐Tumor Immunity Induction via Photodynamic Nanoparticles with Potent Toxic Platinum DNA Intercalator Against Uveal Melanoma

Hui Tao, Jia Tan, Hanchen Zhang et al. · Advanced Science · 2023 · 36 citations · Full text

, , +17

1–5 of 7